UBS kept Hold on Givaudan stock at EUR 4,239.00

Published on 10/19/2026 at 09:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS kept Hold with CHF 3,960.00 target on October 16, 2026. Givaudan stock costs EUR 4,239.00 on October 19, 2026.

Analyst view and sales momentum

Givaudan reported CHF 5,891 million in sales for the first nine months of 2026 on October 13, 2026.
JPMorgan lifted its target to CHF 4,100.00 from CHF 3,700.00 on October 14, 2026.
Givaudan stock trades at EUR 4,239.00 at 9:07 a.m. CEST at Lang & Schwarz on October 19, 2026.
UBS set a CHF 3,960.00 target while maintaining Hold on October 16, 2026.

An isometric 3D illustration of a flavour and fragrance laboratory shown as a detailed cutaway view. Copper distillation columns and glass condensers fill one area. Benches hold test tubes and scent evaluation strips. Scientists in white lab coats work at — Givaudan CH0010645932 isometrisches Aromen-Labor mit kupfernen Destillationsanlagen, Probierstreifen und geordneten übersichtlichen Lagerbereichen, Illustration mit AI erstellt.

Givaudan (ISIN CH0010645932) was trading at EUR 4,239.00 at Lang & Schwarz on October 19, 2026 at 9:07 a.m. CEST. Markets Insider reported on October 16 that UBS analyst Joshua Spector maintained Hold and set a CHF 3,960.00 price target. The analyst view puts the stock's valuation beside a fresh operating update.

Sales growth accelerates in 2026

Givaudan reported CHF 5,891 million in sales for the first nine months of 2026, according to the company's October 13 release. That represented growth of 5.2 percent on a like-for-like basis and 2.6 percent in Swiss francs, compared with 5.7 percent and 1.7 percent respectively in the first nine months of 2025.

The third quarter supplied the strongest comparison. Sales reached CHF 2,092 million, up 11.3 percent in Swiss francs and 8.6 percent on a like-for-like basis from the third quarter of 2025. Fragrance and Beauty generated CHF 3,150 million in the nine-month period, while Taste and Wellbeing contributed CHF 2,741 million.

What does the target imply?

Analyst opinions differ in tone. Markets Insider reported that JPMorgan raised its target from CHF 3,700.00 to CHF 4,100.00 on October 14 and retained an Overweight rating. UBS was more cautious with Hold and a CHF 3,960.00 target, while the latest SIX close was CHF 3,915.00 on October 16.

Upcoming investor dates

Givaudan's next investor event is scheduled for October 29, 2026, according to its investor calendar. The company also lists full-year results for January 27, 2027 in its nine-month sales announcement.

Market value and trading context

Givaudan's market capitalization was CHF 36.1 billion as of October 16, 2026. Its SIX 52-week range was CHF 2,566.00 to CHF 3,948.00, leaving the latest CHF close near the upper end of that interval. The company operates through Fragrance and Beauty and Taste and Wellbeing, linking the investment case to both premium scent demand and flavor solutions.

The stock was trading at EUR 4,239.00 at Lang & Schwarz on October 19, 2026 at 9:07 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.